AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionPark National Corp /oh/
Latest Disclosed Ownership105,506 shares
Latest Disclosed Value $ 22,946,499
Park National Corp /oh/ reports 5.93% increase in ownership of ABBV / AbbVie Inc.

On April 16, 2026 - Park National Corp /oh/ filed a 13F-HR form disclosing ownership of 105,506 shares of AbbVie Inc. (MX:ABBV) valued at $22,946,499 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 5, 2026 disclosing 99,596 shares of AbbVie Inc.. This represents a change in shares of 5.93% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-16 2026-03-31 13F AbbVie Com 00287Y109 105,506 5,910 5.93 22,946 0.83 0.6137
2026-01-05 2025-12-31 13F AbbVie Com 00287Y109 99,596 -10,959 -9.91 22,757 -11.10 0.7097
2025-10-01 2025-09-30 13F AbbVie Com 00287Y109 110,555 -7,072 -6.01 25,598 17.24 0.8007
2025-07-01 2025-06-30 13F AbbVie Com 00287Y109 117,627 -9,546 -7.51 21,834 -18.06 0.7202
2025-04-02 2025-03-31 13F AbbVie Com 00287Y109 127,173 -9,524 -6.97 26,645 9.69 0.9797
2025-01-08 2024-12-31 13F AbbVie Com 00287Y109 136,697 -1,937 -1.40 24,291 -11.27 0.8900
2024-10-01 2024-09-30 13F AbbVie Com 00287Y109 138,634 -7,465 -5.11 27,377 9.25 0.9586
2024-07-15 2024-06-30 13F AbbVie Com 00287Y109 146,099 11,673 8.68 25,059 2.37 0.9262
2024-04-01 2024-03-31 13F AbbVie Com 00287Y109 134,426 -10,771 -7.42 24,479 8.79 0.9430
2024-01-02 2023-12-31 13F AbbVie Com 00287Y109 145,197 -6,663 -4.39 22,501 -0.60 0.9206
2023-10-02 2023-09-30 13F AbbVie Com 00287Y109 151,860 3,295 2.22 22,636 13.09 1.0225
2023-07-03 2023-06-30 13F AbbVie Com 00287Y109 148,565 7,907 5.62 20,016 -10.71 0.8718
2023-04-03 2023-03-31 13F AbbVie Com 00287Y109 140,658 39,840 39.52 22,417 37.58 0.9985
2023-02-06 2022-12-31 13F AbbVie Com 00287Y109 100,818 -8,921 -8.13 16,293 10.63 0.7259
2022-10-03 2022-09-30 13F AbbVie Com 00287Y109 109,739 33,673 44.27 14,728 26.42 0.7395
2022-07-06 2022-06-30 13F/A-1 AbbVie Com 00287Y109 76,066 -2,368 -3.02 11,650 -8.38 0.5606
2022-07-01 2022-06-30 13F AbbVie Com 00287Y109 76,066 -2,368 11,650 0.2943
2022-04-01 2022-03-31 13F AbbVie Com 00287Y109 78,434 -6,851 -8.03 12,715 10.12 0.5286
2022-01-04 2021-12-31 13F AbbVie Com 00287Y109 85,285 -16,698 -16.37 11,547 4.96 0.4506
2021-10-01 2021-09-30 13F AbbVie Com 00287Y109 101,983 -5,775 -5.36 11,001 -9.37 0.4635
2021-07-01 2021-06-30 13F AbbVie Com 00287Y109 107,758 -11,248 -9.45 12,138 -5.75 0.5091
2021-04-01 2021-03-31 13F AbbVie Com 00287Y109 119,006 -30,965 -20.65 12,879 -19.85 0.5646
2021-01-04 2020-12-31 13F AbbVie Com 00287Y109 149,971 -11,740 -7.26 16,069 13.44 0.7527
2020-10-01 2020-09-30 13F AbbVie Com 00287Y109 161,711 -32,680 -16.81 14,165 -25.78 0.7435
2020-07-01 2020-06-30 13F AbbVie Com 00287Y109 194,391 -11,512 -5.59 19,085 21.65 1.0687
2020-04-01 2020-03-31 13F AbbVie Com 00287Y109 205,903 -17,746 -7.93 15,688 -20.78 0.9946
2020-01-02 2019-12-31 13F AbbVie Com 00287Y109 223,649 -13,541 -5.71 19,802 10.26 1.0062
2019-10-01 2019-09-30 13F AbbVie Com 00287Y109 237,190 -68,495 -22.41 17,960 -19.20 0.9769
2019-07-01 2019-06-30 13F AbbVie Com 00287Y109 305,685 5,472 1.82 22,229 -8.12 1.2080
2019-04-01 2019-03-31 13F AbbVie Com 00287Y109 300,213 14,906 5.22 24,194 -8.01 1.3611
2019-01-02 2018-12-31 13F AbbVie Com 00287Y109 285,307 15,569 5.77 26,302 3.10 1.6287
2018-10-02 2018-09-30 13F AbbVie Com 00287Y109 269,738 5,245 1.98 25,512 4.11 1.3999
2018-07-02 2018-06-30 13F AbbVie Com 00287Y109 264,493 6,583 2.55 24,505 0.39 1.4053
2018-04-02 2018-03-31 13F AbbVie Com 00287Y109 257,910 -18,426 -6.67 24,411 -8.66 1.4171
2018-01-02 2017-12-31 13F AbbVie Com 00287Y109 276,336 -14,447 -4.97 26,724 3.43 1.4936
2017-10-02 2017-09-30 13F AbbVie Com 00287Y109 290,783 -1,548 -0.53 25,839 21.90 1.4814
2017-07-03 2017-06-30 13F AbbVie Com 00287Y109 292,331 6,916 2.42 21,197 13.98 1.2580
2017-04-03 2017-03-31 13F AbbVie Com 00287Y109 285,415 13,007 4.77 18,597 9.02 1.1184
2017-01-03 2016-12-31 13F AbbVie Com 00287Y109 272,408 19,902 7.88 17,058 7.11 1.0380
2016-10-03 2016-09-30 13F AbbVie Equity 00287Y109 252,506 -2,517 -0.99 15,925 0.86 1.0134
2016-07-01 2016-06-30 13F AbbVie Equity 00287Y109 255,023 16,095 6.74 15,789 15.69 1.0084
2016-04-01 2016-03-31 13F AbbVie Equity 00287Y109 238,928 22,356 10.32 13,648 6.38 0.9027
2016-01-04 2015-12-31 13F AbbVie Equity 00287Y109 216,572 31,941 17.30 12,829 27.70 0.8690
2015-10-01 2015-09-30 13F AbbVie Equity 00287Y109 184,631 17,161 10.25 10,046 -10.72 0.7211
2015-07-01 2015-06-30 13F AbbVie Equity 00287Y109 167,470 -1,224 -0.73 11,252 13.94 0.7707
2015-04-01 2015-03-31 13F AbbVie Equity 00287Y109 168,694 -8,234 -4.65 9,875 -14.71 0.6692
2015-01-02 2014-12-31 13F AbbVie Equity 00287Y109 176,928 -3,360 -1.86 11,578 11.19 0.7659
2014-10-01 2014-09-30 13F AbbVie Equity 00287Y109 180,288 456 0.25 10,413 2.60 0.7567
2014-07-01 2014-06-30 13F AbbVie Equity 00287Y109 179,832 -12,021 -6.27 10,150 2.92 0.6958
2014-04-01 2014-03-31 13F AbbVie Equity 00287Y109 191,853 -48,568 -20.20 9,861 -99.92 0.7011
2014-01-03 2013-12-31 13F AbbVie Equity 00287Y109 240,421 -6,299 -2.55 12,696,633 15.05 0.9042
2013-10-01 2013-09-30 13F AbbVie Equity 00287Y109 246,720 1,371 0.56 11,035,785 8.80 0.8441
2013-07-05 2013-06-30 13F AbbVie Equity 00287Y109 245,349 245,349 10,142,728 0.8202
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.